Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma

Molecular Vision

Volumn 14, Issue , 2008, Pages 1437-1445

  Grus, F H ^a   Joachim, S C ^a   Sandmann, S ^a   Thiel, U ^a   Bruns, K ^a   Lackner, K J ^a   Pfeiffer, N ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PREALBUMIN;

AQUEOUS HUMOR; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MICROARRAY; SAMPLING; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

AGED; AQUEOUS HUMOR; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; GLAUCOMA, OPEN-ANGLE; HUMANS; PREALBUMIN; ROC CURVE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 49349112388     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Knauer C, Pfeiffer N. Ophthalmologe 2006: 103:735-41.
2. Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefansson E. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002: 21:359-93.
3. Grieshaber MC, Orgul S, Schoetzau A, Flammer J. Relationship between retinal glial cell activation in glaucoma and vascular dysregulation. J Glaucoma 2007; 16:215-9.
4. Kumar DM, Agarwal N. Oxidative stress in glaucoma: a burden of evidence. J Glaucoma 2007; 16:334-43.
5. Grus FH, Joachim SC, Wuenschig D, Rieck J, Pfeiffer N. Autoimmunity and glaucoma. J Glaucoma 2008: 17:79-84.
6. Koliakos GG, Konstas AG, Schlotzer-Schrehardt U, Hollo G, Katsimbris IE, Georgiadis N, Ritch R. 8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 2003; 87:353-6.
7. Koliakos GG, Konstas AG, Schlotzer-Schrehardt U, Hollo G, Mitova D, Kovatchev D, Maloutas S, Georgiadis N. Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 2004; 88:523-7.
8. Koliakos GG, Konstas AG, Dimitrakoulias N, Triantos A, Kardasopoulos A, Dimitriadou A, Trakatellis AC. Possible role of transferrin in exfoliation syndrome, Acta Ophthalmol Scent 1996; 74:155-9.
9. Denis P, Nordmann JP, Elena PP, Saraux H, Lapalus P. Central. nervous system control of intraocular pressure. Fundam Clin Pharmacol 1994; 8:230-7.
10. Lutjen-Drecoll E, Gabelt BT, Tian B, Kaufman PL. Outflow of aqueous humor. J Glaucoma 2001; 10:S42-4.
11. Society TEG. Terminology and guidelines for glaucoma. www.eugs.org 2006; Ind edition.
12. Dooremal JC. Die Entwicklung der in fremden Grund versetzten lebenden Gewebe. Graefes Arch Clin Exp Ophthalmol 1873; 13:359-73.
13. Schlotzer-Schrehardt U, Lommatzsch J, Kuchle M, Konstas AG, Naumann GO. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2003; 44:1117-25.
14. Maatta M, Tervahartiala T, Vesti E, Airaksinen J, Sorsa T. Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma. J Glaucoma 2006:15:229-37.
15. Funding M, Vorum H, Honore B, Nexo E, Ehlers N. Proteomic analysis of aqueous humour from patients with acute corneal rejection. Acta Ophthalmol Scent 2005; 83:31-9.
16. Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 2004; 137:62-9.
17. Berlau J, Lorenz P, Beck R, Makovitzky J, Schlotzer-Schrehardt U, Thiesen HJ, Guthoff R. Analysis of aqueous humour proteins of eyes with and without pseudoexfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2001: 239:743-6.
18. Duan X, Lu Q, Xue P, Zhang H, Dong Z, Yang F, Wang N. Proteomic analysis of aqueous humor from patients with myopia. Mol Vis 2008; 14:370-7.
19. Herber S, Grus FH, Sabuncuo P, Augustin AJ. Changes in the tear protein patterns of diabetic patients using two-dimensional electrophoresis. Adv Exp Med Biol 2002: 506:623-6.
20. Grus FH, Sabuncuo P, Herber S, Augustin AJ. Analysis of tear protein patterns for the diagnosis of dry eye. Adv Exp Med Biol 2002: 506:1213-6.
21. Herber S, Grus FH, Sabuncuo P, Augustin AJ. Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis 2001; 22:1838-44.
22. Oakley BR, Kirsch DR, Morris NR. A simplified ultrasensitive silver stain for detecting proteins in polyacrylumide gels. Anal Biochem 1980; 105:361-3.
23. Traeger M, Eberhart A, Geldner G, Morin AM, Putzke C, Wulf H, Eberhart LH. Anaesthesist 2003; 52:1055-61.
24. Grus FH, Augustin AJ, Pfeiffer N, Schmidt-Erfurth U. Ophthalmologe 2001; 98:1132-7.
25. Joachim SC, Reichelt J, Berneiser S, Pfeiffer N, Grus FH. Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens. Graefes Arch Clin Exp Ophthalmol 2008; 246:573-80.
26. Joachim SC, Wuenschig D, Pfeiffer N, Grus FH. IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma. Mol Vis 2007; 13:1573-9.
27. Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH. Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration, Graefes Arch Clin Exp Ophthalmol 2007; 245:619-26.
28. Grus FH, Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Wax MB. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States. Invest Ophthalmol Vis Sci 2006; 47:968-76.
29. EMBL. http://www.narrador.embl-eidelberg.de/Visitor_Facility/ Homepage.html. 2006.
30. Monaco HL, Rizzi M, Coda A. Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 1995; 268:1039-41.
31. Hou X, Aguilar MI, Small DH. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J 2007; 274:1637-50.
32. Connors LH, Ericsson T, Skare J, Jones LA, Lewis WD, Skinner M. A simple screening test for variant transthyretins associated with familial transthyretin amyloidosis using isoelectric focusing. Biochim Biophys Acta 1998; 1407: 185-92.
33. Lei M, Yang M, Huo S. Intrinsic versus mutation dependent instability/ flexibility: a comparative analysis of the structure and dynamics of wild-type transthyretin and its pathogenic variants. J Struct Biol 2004; 148:153-68.
34. Schweigert FJ, Wirth K, Raila J. Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay. Proteome Sci 2004: 2:5.
35. Bergen HR 3rd, Zeldenrust SR, Butz ML, Snow DS, Dyck PJ, Dyck PJ, Klein CJ, O'Brien JF. Thibodeau SN, Muddiman DC. Identification of transthyretin variants by sequential proteomic and genomic analysis. Clin Chem 2004; 50:1544-52.
36. Kawaji T, Ando Y, Nakamura M, Yamamoto K, Ando E, Takano A, Inomata Y, Hirata A, Tanihara H. Transthyretin synthesis in rabbit ciliary pigment epithelium. Exp Eye Res 2005; 81:306-12.
37. Dwork AJ, Cavallaro T, Martone RL, Goodman DS, Schon EA, Herbert J. Distribution of transthyretin in the rat eye. Invest Ophthalmol Vis Sci 1990; 31:489-96.
38. Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P. Expression of acute-phase response proteins in retinal Muller cells in diabetes. Invest Ophthalmol Vis Sci 2005; 46:349-57.
39. Naishiro Y, Suzuki C, Kimura M, Yamamoto M, Takahashi H, Sohma H, Hori T, Shinomura Y, Kokai Y, Imai K. Nihon Rinsho Meneki Gakkai Kaishi 2007: 30:145-50. Plasma analysis of rheumatoid arthritis by SELDI
40. Lovell MA, Lynn BC, Xiong S, Quinn JF, Kaye J, Markesbery WR. An aberrant protein complex in CSF as a biomarker of Alzheimer disease. Neurology 2008: 70:2212-8.
41. Finehout EJ, Franck Z, Choe LH, Relkin N, Lee KH. Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Ann Neurol 2007. 61:120-9.
42. Serot JM, Christmann D, Dubost T, Couturier M. Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1997; 63:506-8.
43. Rompp A, Dekker L, Taban I, Jenster G, Boogerd W, Bonfrer H, Spengler B, Heeren R, Smitt PS, Luider TM. Identification of leptomeningeal metastasis-related proteins in cerebrospinal fluid of patients with breast cancer by a combination of MALDI-TOF. MALDI-FTICR and nanoLC-FTICR MS. Proteomics 2007: 7:474-81.
44. Yang YR, Liu SL, Qin ZY, Liu FJ, Qin YJ, Bai SM, Chen ZY. Comparative proteomics analysis of cerebrospinal fluid of patients with guillain-barre syndrome. Cell Mol Neurobiol 2008; 28:737-44.